Hongfang Jin Selected Research

Vasovagal Syncope

1/2022	Predictor of Syncopal Recurrence in Children With Vasovagal Syncope Treated With Metoprolol.
1/2021	Efficacy of Increased Salt and Water Intake on Pediatric Vasovagal Syncope: A Meta-Analysis Based on Global Published Data.
1/2019	Baroreflex Sensitivity Predicts Response to Metoprolol in Children With Vasovagal Syncope: A Pilot Study.
10/2018	Left Ventricular Ejection Fraction and Fractional Shortening are Useful for the Prediction of the Therapeutic Response to Metoprolol in Children with Vasovagal Syncope.
4/2015	Erythrocytic hydrogen sulfide production is increased in children with vasovagal syncope.
10/2014	Assessment of therapeutic biomarkers in the treatment of children with postural tachycardia syndrome and vasovagal syncope.
2/2012	Plasma hydrogen sulfide in differential diagnosis between vasovagal syncope and postural orthostatic tachycardia syndrome in children.
4/2008	Randomized comparison of metoprolol versus conventional treatment in preventing recurrence of vasovagal syncope in children and adolescents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongfang Jin Research Topics

Disease

21	Postural Orthostatic Tachycardia Syndrome 01/2021 - 01/2011
12	Inflammation (Inflammations) 01/2022 - 01/2004
8	Vasovagal Syncope 01/2022 - 04/2008
8	Hypertension (High Blood Pressure) 01/2022 - 01/2014
8	Pulmonary Hypertension 01/2022 - 11/2008
6	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2022 - 08/2015
5	Hypertrophy 01/2022 - 12/2016
5	Atherosclerosis 01/2022 - 04/2011
4	Syncope (Fainting) 01/2022 - 04/2008
4	Acute Lung Injury 01/2022 - 09/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2022 - 01/2016
3	Brain Injuries (Brain Injury) 01/2022 - 02/2018
3	Epilepsy (Aura) 01/2022 - 02/2018
3	Vascular Remodeling 11/2021 - 10/2016
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 11/2013
3	Hypoxia (Hypoxemia) 01/2021 - 01/2010
2	Vascular Calcification 01/2022 - 02/2016
2	Cardiotoxicity 01/2022 - 01/2018
2	Vascular Diseases (Vascular Disease) 01/2022 - 01/2017
2	Nervous System Diseases (Neurological Disorders) 02/2018 - 02/2018
2	Seizures (Absence Seizure) 02/2018 - 02/2018
2	Ischemia 11/2013 - 02/2009
1	Neoplasm Metastasis (Metastasis) 07/2022
1	Osteosarcoma (Osteogenic Sarcoma) 07/2022
1	Colitis 01/2022
1	Exanthema (Rash) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Fever (Fevers) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Congenital Heart Defects (Congenital Heart Defect) 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Hypothyroidism 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Pathologic Processes 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2021
1	Coronary Aneurysm (Aneurysm, Coronary) 07/2021
1	Coronary Thrombosis 07/2021
1	Diabetes Mellitus 01/2021
1	Insulin Resistance 01/2021
1	Left Ventricular Dysfunction 01/2021
1	Orthostatic Intolerance 01/2020

Drug/Important Bio-Agent (IBA)

23	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 09/2022 - 09/2008
14	Sulfur DioxideIBA 01/2022 - 02/2009
9	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2022 - 04/2008
8	SaltsIBA 01/2021 - 08/2012
8	Midodrine (Midon)FDA LinkGeneric 06/2015 - 01/2011
5	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 02/2015
4	MonocrotalineIBA 01/2022 - 10/2016
4	CollagenIBA 01/2021 - 11/2008
3	Pharmaceutical PreparationsIBA 01/2022 - 02/2018
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 08/2015
3	GasotransmittersIBA 01/2022 - 02/2015
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2014
3	Oleic Acid (Oleate)IBA 11/2017 - 09/2008
3	ORALIT (ORS)IBA 01/2017 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 10/2015 - 08/2014
3	AdrenomedullinIBA 06/2015 - 07/2012
3	sodium bisulfide (NaHS)IBA 06/2015 - 02/2009
2	EnzymesIBA 07/2022 - 10/2019
2	SulfurIBA 01/2022 - 01/2018
2	PotassiumIBA 01/2022 - 01/2018
2	SodiumIBA 01/2022 - 08/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2021 - 02/2016
2	Angiotensin IIIBA 01/2021 - 12/2016
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2021 - 02/2009
2	AntioxidantsIBA 10/2020 - 01/2017
2	NF-kappa B (NF-kB)IBA 01/2020 - 01/2004
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 09/2008
2	Biological ProductsIBA 01/2020 - 01/2017
2	Cysteine (L-Cysteine)FDA Link 10/2019 - 04/2014
2	CystathionineIBA 10/2019 - 01/2017
2	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2018 - 05/2013
2	Erythropoietin FDA Link 02/2018 - 02/2018
2	SolutionsIBA 10/2016 - 02/2009
2	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 06/2015 - 01/2015
2	oxidized low density lipoproteinIBA 04/2014 - 06/2010
1	AnthracyclinesIBA 01/2022
1	Thyroid HormonesIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	C-Reactive ProteinIBA 01/2022
1	BilirubinIBA 01/2022
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Prealbumin (Transthyretin)IBA 01/2022
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 11/2021
1	Aspartic Acid (Aspartate)FDA Link 11/2021
1	Clopidogrel (Plavix)FDA Link 07/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021
1	Taurine FDA Link 01/2021

Therapy/Procedure

8	Therapeutics 01/2022 - 04/2008
4	Drug Therapy (Chemotherapy) 01/2020 - 01/2014
3	Fluid Therapy (Oral Rehydration Therapy) 01/2017 - 01/2015
1	Intravenous Injections 01/2022